BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34890415)

  • 1. Demographic differentials of lung cancer survival in Bangladeshi patients.
    Islam MR; Hasan ATMK; Khatun N; Ridi IN; Rasheed MMO; Islam SMA; Karim MN
    PLoS One; 2021; 16(12):e0261238. PubMed ID: 34890415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Influence of Comorbidity and the Simplified Comorbidity Score on Overall Survival in Non-Small Cell Lung Cancer-A Prospective Cohort Study.
    Alexander M; Evans SM; Stirling RG; Wolfe R; Officer A; MacManus M; Solomon B; Burbury K; Ball D
    J Thorac Oncol; 2016 May; 11(5):748-757. PubMed ID: 26851495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a patient-centered aggregate score to predict survival after lung resection for non-small cell lung cancer.
    Brunelli A; Salati M; Refai M; Xiumé F; Berardi R; Mazzanti P; Pompili C
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):385-90.e1-2. PubMed ID: 23651911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in population-based survival of stage IV NSCLC due to increased use of chemotherapy.
    Aarts MJ; van den Borne BE; Biesma B; Kloover JS; Aerts JG; Lemmens VE
    Int J Cancer; 2015 Mar; 136(5):E387-95. PubMed ID: 25219898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis.
    Foster CC; Sher DJ; Rusthoven CG; Verma V; Spiotto MT; Weichselbaum RR; Koshy M
    Radiat Oncol; 2019 Jan; 14(1):18. PubMed ID: 30691492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy and survival in advanced non-small cell lung carcinoma: is pneumologists' skepticism justified?].
    Gullón Blanco JA; Suárez Toste I; Fernández Alvarez R; Rubinos Cuadrado G; Medina Gonzálvez A; Galindo Morales R; González Martín IJ
    Arch Bronconeumol; 2006 Jun; 42(6):273-7. PubMed ID: 16827975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung Cancer Survival with Current Therapies and New Targeted Treatments: A Comprehensive Update from the Srinagarind Hospital-Based Cancer Registry from (2013 to 2017).
    Musika W; Kamsa-Ard S; Jirapornkul C; Santong C; Phunmanee A
    Asian Pac J Cancer Prev; 2021 Aug; 22(8):2501-2507. PubMed ID: 34452564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Socioeconomic position and survival after lung cancer: Influence of stage, treatment and comorbidity among Danish patients with lung cancer diagnosed in 2004-2010.
    Dalton SO; Steding-Jessen M; Jakobsen E; Mellemgaard A; Østerlind K; Schüz J; Johansen C
    Acta Oncol; 2015 May; 54(5):797-804. PubMed ID: 25761702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
    Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival rates and predictors of survival among colorectal cancer patients in a Malaysian tertiary hospital.
    Magaji BA; Moy FM; Roslani AC; Law CW
    BMC Cancer; 2017 May; 17(1):339. PubMed ID: 28521746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy.
    Sehgal K; Gill RR; Widick P; Bindal P; McDonald DC; Shea M; Rangachari D; Costa DB
    JAMA Netw Open; 2021 Feb; 4(2):e2037120. PubMed ID: 33570575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Treatment, Survival Rates, and Factors related to Survival of Stage III Lung Cancer Patients Treated at Srinagarind Hospital, Faculty of Medicine, Khon Kaen University, Thailand.
    Raksasri N; Kamsa-Ard S; Musika W; Santong C; Phunmanee A
    Asian Pac J Cancer Prev; 2023 May; 24(5):1743-1749. PubMed ID: 37247297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
    Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic factors for limited-stage small cell lung cancer: a study of 284 patients.
    Chen J; Jiang R; Garces YI; Jatoi A; Stoddard SM; Sun Z; Marks RS; Liu Y; Yang P
    Lung Cancer; 2010 Feb; 67(2):221-6. PubMed ID: 19497635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaplastic meningioma: an analysis of the National Cancer Database from 2004 to 2012.
    Orton A; Frandsen J; Jensen R; Shrieve DC; Suneja G
    J Neurosurg; 2018 Jun; 128(6):1684-1689. PubMed ID: 28731397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of survival rates in patients with lung cancer in west Azerbaijan, the northwest of Iran.
    Abazari M; Gholamnejad M; Roshanaei G; Abazari R; Roosta Y; Mahjub H
    Asian Pac J Cancer Prev; 2015; 16(9):3923-6. PubMed ID: 25987061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal trends from 1986 to 2008 in overall survival of small cell lung cancer patients.
    Schabath MB; Nguyen A; Wilson P; Sommerer KR; Thompson ZJ; Chiappori AA
    Lung Cancer; 2014 Oct; 86(1):14-21. PubMed ID: 25115410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of lung cancer risk factors and mortality in Qatar: A case series study.
    Abdel-Salam AG; Mollazehi M; Bandyopadhyay D; Malki AM; Shi Z; Zayed H
    Cancer Rep (Hoboken); 2021 Feb; 4(1):e1302. PubMed ID: 33026195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of comorbidity upon determinants of outcome in patients with lung cancer.
    Grose D; Morrison DS; Devereux G; Jones R; Sharma D; Selby C; Docherty K; McIntosh D; Nicolson M; McMillan DC; Milroy R;
    Lung Cancer; 2015 Feb; 87(2):186-92. PubMed ID: 25498829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical predictors of survival in young patients with small cell lung cancer: Results from the California Cancer Registry.
    Lara JD; Brunson A; Riess JW; Kelly K; Lara PN; Gandara DR
    Lung Cancer; 2017 Oct; 112():165-168. PubMed ID: 29191590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.